Pharmexcil Patent Awards 2008-09 Flyer
	Pharmexcil Patent Awards Invitation for Nomination 2011-12
	Pharmexcil Patent Awards Flyer 2010-2011
	Pharmexcil Patent Awards Flyer 2009-10

	Indian Patent Office
	African Intellectual Property Organization (OAPI).
	Austrian Intellectual Property Organization.
	African Regional Intellectual Property Organization.
	Australia: IP Australia
	Brazil Patent Search
	Canada: Canadian Intellectual Property Office
	China: China Patent & Trademark office
	Europe: European Patent Office
	Japan: Japanese Patent Office
	Korea: Korean Intellectual Property Office
	New Zealand: Intellectual Property Office of New Zealand (IPONZ)
	Russia: Russian Agency for Patent and Trademarks
	Singapore: Intellectual Property Office of Singapore
	South Africa: South Africa Patent office
	Trinidad & Tobago: The Intellectual Property Office (IPO)
	UK: UK Patent Office
	US: United States Patent and Trade Marks Office (USPTO)
	Eurasian Patent Office
	World Intellectual Property Organisation

	How to Calculate Standard Patent Expiry Dates and Data Exclusivity in Key Territories
	A Detailed Study of Patent System For Protection Of Inventions-Review Article
	Anatomy of a US Patent Document

	Infringement Analysis as on 24th August, 2012 at Chennai
	Patentable Subject Matter on 24th August, 2012 at Chennai
	Drugs Which are Not Patentable on 26th July, 2012 at Ahmedabad
	Patent Filing Procedures (National/International) on 26th July, 2012 at Ahmedabad
	Introdution to IPR on 26th July, 2012 at Ahmedabad
	PCT Application Filing and its advantages on 22nd June 2012 at Mumbai
	Prior Art-Patent Search (Dialog Pro) on 22nd June 2012 at Mumbai
	Introduction to Intellectual Property Rights on 22nd June 2012 at Mumbai
	Patentability assessment presented on 23rd May, 2012 at Hyderabad
	Freedom to Operate presented on 23rd May, 2012 at Hyderabad
	Introduction to Patent Search and its applications in Pharmaceutical Industry presented on 23rd May, 2012 at Hyderabad
	Patent Office Procedures on 18th November, 2010 at Bangalore
	Basics of IPR on 18th November, 2010 at Bangalore
	Issues Related to Counterfiet Drugs on 24th November, 2010 at Ahmedabad
	Basics of IPR on 24th November, 2010 at Ahmedabad
	Patent Search on 18th November, 2010 at Bangalore
	Presentation of Prof. Dr. Abbott

	INID Numbers-Internationally agreed Numbers for the Identification of bibligraphic Data
	Patent Kinds of different Industrial Property Offices
	Kind Codes Included on the USPTO Patent Documents
	Country Names and Two-Letter Code for PCT Applicants
	Directory of Intellectual Property Offices
	Member States of the European Patent Organisation
	Patent Cooperation Treaty (PCT) Contracting States
	Member states of WIPO
	Member States of WTO

	Strategies for Generic Drug Development on 24th August, 2012 at Chennai
	WHOGMP Guidelines on 24th Aug, 2012 at Chennai
	WHOGMP-ICH Guidelines on 26th July, 2012 at Ahmedabad
	eCTD Submissions on 22nd June 2012 at Mumbai
	EU Directive-PICS and its implications presented on 23rd May, 2012 at Hyderabad
	eCTD on 24th November, 2010 at Ahmedabad
	Presentation on Brand India Promotion on 24th November, 2010 at Ahmedabad
	Good Laboratory Practices on 24th November, 2010 at Ahmedabad
	Good Laboratory Practices-Sch L1 on 18th November, 2010 at Bangalore
	Export Requirements on 18th November, 2010 at Bangalore
	eCTD on 18th November, 2010 at Bangalore

	List of Indian Companies/Sites Registered at USFDA as on 11th March, 2013
	US Manual of Policies and Procedures relating Generic Drug Labeling Revision
	List of Indian Company Sites Registered by USFDA as on 31st Oct 2011

	Strategies and Lead Resources for Generic Drug Development
	Current Status of Pharmaceutical Patenting at USPTO
	Knowledge Resources: A Lead to Pharmaceutical Industry Growth
	Current Status of Pharmaceutical Patenting in India
	Dynamics of Drug Master Filings at USFDA
	Global Pharmaceutical Trade and Contribution of India

	Patentability of Miroorganisms-Final Judgment of Diamond vs Chakrabarty
	Diamond v. Chakrabarty: A Retrospective on 25 Years of Biotech Patents
	Patentability of Biological Material(s) - Essentially, Therapeutic Antibodies - in India
	Competition Assessment of Pharmaceutical Sector in India
	Managing Intellectual Property as a Competitive Strategy
	Intellectual Property Rights in Pharma Industry Growth of Indian Pharmaceutical Industry:Impact of Indian, US and European Patent Laws and Regulatory Requirements
	Intellectual Property Rights in Pharma Industry
	Analysis of Patent Filing Procedure in India Protect Your Scientific Intellectual Property
	Analysis of Patent Filing Procedure in India
	Searching Prior Art with Markush Patents for novel pharmaceuticals Intellectual Property Rights and its Development in India
	Searching Prior Art with Markush Patents for novel pharmaceuticals
	TRIPS, WTO and IPR: Impact of Indian Patent Act 2005 on Indian Pharmaceutical Industry
	Patent licensing: Global Perspective and Analysis of Case Studies
	Intellectual Property Protection and US Foreign Direct Investment in Emerging Economies
	TRIPS, WTO and IPR – Counterfeit Drugs
	Compulsory Licensing under TRIPS: How Far it Addresses Public Health Concerns in Developing Nations
	Facilitating Access or Monopoly: Patent Pools at the Interface of Patent and Competition Regimes
	TRIPS, WTO and IPR - The Year 2009 in Retrospect
	IP Audit: Way to a Healthy Organization
	Approaches to Ensuring Access to Pharmaceuticals under the New China’s Patent Law

	Supreme Court of India Judgement on Novartis Case Relating to Imatinib
	Pre grant opposition on Nevirapine composition for HIV treatment
	Post grant opposition on propane diol derivative
	Pfizer vs Ranbaxy case relating to Lipitor
	Omeprazole Case Study2
	Omeprazole Case Study1
	Olmesartan Case Study
	Judgement Relating to First Indian Compulsory License
	Doctrine of Equivalence Case Study
	Doctrine of Equivalence Case Study
	Astrazeneca vs Apotex Relating to Rosuvastatin Patented Methods
	Patentability of Microorganisms-Final Judgement-Diamond vs Chakrbarty
	Dev Pharma v. Sunovion-2011-1507
	Bayer v. Lupin and Bayer v. Sandoz and Watson-2011-1143, -1228

	Note on Drug Master Filings with USFDA by Indian Pharmaceutical Companies (Type II-Active)
	Note on Inactive Ingredients-Approved by USFDA for Various Drug Formulations (For Different Dosage Forms with Specified Route of Administration)-Inner pages
	Title Page of "Note on Inactive Ingredients-Approved by USFDA for Various Drug Formulations (For Different Dosage Forms with Specified Route of Administration)

Exploring Branded Generics Drugs by Indian Pharmaceutical Multinational Companies as a New Prospect

	Indian Manual of Patent Office Procedures
	Indian Patent Rules 2003 Eversion pdf
	Indian Patent Act 1970-Eversion pdf